Photocathodic analysis has an excellent anti-interference property but suffers from a weak response signal, restricting its sensitivity and applicability in trace-level assays. Here, a 55-fold amplification of the photocathodic response signal was achieved. On the one hand, polydopamine (PDA) modification of CuO to form a new Z-scheme CuO@PDA photocathode was used as a preliminary amplifier to amplify the cathodic photocurrent by 2.7 times. On the other hand, the developed CdIn₂S₄/CdS photoanode with an ultralarge anodic photocurrent was used as an external signal amplifier to further enhance the cathodic photocurrent by 20.6 times. Consequently, a self-powered dual-photoelectrode photoelectrochemical (PEC) sensing platform with an ultralarge cathodic photocurrent was developed for a sensitive activity assay of caspase-3, the key mediator of cell apoptosis. Ac-GDGDEVDCC-NH₂ peptide (HS-Peptide) was designed and modified onto the CuO@PDA/ITO photocathode through the Michael addition reaction between the carbonyl group of PDA and the thiol group of HS-Peptide, and then, the electrode was further blocked by 6-mercaptohexanol. Due to the steric hindrance caused by the HS-Peptide, the PEC signal was significantly reduced. When caspase-3 was present, the DEVD sequence in the HS-Peptide was specifically recognized and cleaved, resulting in the obvious recovery of the PEC response, thus achieving the sensitive activity assay of caspase-3 (linear response range, 10 fg mL⁻¹ to 1 μg mL⁻¹; detection limit, 1.1 fg mL⁻¹). Besides, the biosensing platform showed satisfactory recovery in the cell lysate. In view of the ultralarge photocathodic current, the developed self-powered dual-photoelectrode PEC sensing platform should have great promising applications in bioanalysis and early disease diagnosis.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: